Eli Lilly | LLY - Capital Ordinário

Preço das Ações
987.02
Mudança Diária
-1.85 -0.19%
Mensal
6.01%
Anual
27.08%
Q2 Previsão
943.29




Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 23.39B 2025-09
ALKERMES USD 165.61M 503K 2025-12
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Baxter International USD 516.45M 2.17M 2026-03
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Drreddys Laboratories INR 832.57M 53K 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Glaxosmithkline GBP 4.08B 49.43M 2025-12
J&J USD 2.41B 1.74M 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merck USD 2.47B 12.72M 2025-12
Neurocrine Biosciences USD 100.6M 500K 2026-03
Novartis USD 1.91B 60K 2026-03
Novartis USD 1.91B 10.64M 2025-12
Novo Nordisk DKK 4.44B 0 2025-12
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.7B 13M 2026-03
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.32M 765K 2025-12
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
United Therapeutics USD 43.64M 740K 2025-12
Zoetis USD 424.93M 16.54M 2025-12